Continuous Positive Airway Pressure (CPAP)
Treatment for Sleep Apnea
Typical Dosage: 4-20 cm H2O (titrated pressure)
Effectiveness
90%
Safety Score
85%
Clinical Trials
647
Participants
200K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
85
DangerousModerateSafe
Treatment Details
Dosage Range
4-20 cm H2O (titrated pressure)
Time to Effect
Immediate
Treatment Duration
Lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
2(Treat 2 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$150
Side Effect Mgmt:$50
Total Annual:$800
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$35,000/QALY
QALYs Gained
0.75
Outcome-Based Costs
Cost per Responder
$1,067
Cost per Remission
$1,067
Continuous Positive Airway Pressure (CPAP) Outcomes
for Sleep Apnea
Active Clinical Trials
1 active trial recruiting for Continuous Positive Airway Pressure (CPAP) in Sleep Apnea
XOR Levels in OSA Patients (XOR-OSA)
NCT06554496RECRUITINGNA
80 participants
INTERVENTIONAL
Nanjing, China
Started: Jul 1, 2024
Completed Clinical Trials
14 completed trials for Continuous Positive Airway Pressure (CPAP) in Sleep Apnea
Circadian Intraocular Pressure Patterns in Patients With Sleep Apnea Syndrome and Treatment With Continuous Air Pressure
NCT06152692COMPLETEDNA
111 participants
INTERVENTIONAL
Lleida, Spain
Started: Jan 1, 2016
Randomized-controlled Trial (RCT) on CPAP-withdrawal and Microvascular Function in OSA
NCT01797653COMPLETEDNA
45 participants
INTERVENTIONAL
Zurich, Switzerland
Started: Feb 1, 2013
The Impact of Obstructive Sleep Apnea in Erectile Dysfunction
NCT03086122COMPLETEDNA
140 participants
INTERVENTIONAL
Lleida, Spain
Started: Apr 1, 2013
Effect of CPAP Treatment in Elderly: Randomized Clinical Trial
NCT02069600COMPLETEDPHASE3
224 participants
INTERVENTIONAL
Valencia, Spain
Started: Jan 1, 2011
Effect of Nasal Continuous Positive Airway Pressure (CPAP) Blood Pressure and Vascular Endothelial Growth Factor in Obstructive Sleep Apnea Syndrome
NCT00300872COMPLETEDNA
140 participants
INTERVENTIONAL
Shatin, Hong Kong
Started: Jan 1, 2005
Change in C-reactive Protein (CRP) in Men and Women With Sleep Apnea After Continuous Positive Airway Pressure (CPAP)
NCT01365832COMPLETEDNA
436 participants
INTERVENTIONAL
Heraklion, Greece
Started: Jan 1, 2007
Continuous Positive Airway Pressure as a Potential New Treatment for Cluster Headache
NCT03397563COMPLETEDNA
30 participants
INTERVENTIONAL
Trondheim, Norway
Started: Jan 16, 2018
An Investigation to Test the Efficacy of the High Flow (HF) Continuous Positive Airway Pressure (CPAP) in Patients With Obstructive Sleep Apnea (OSA)
NCT01025440COMPLETEDNA
25 participants
INTERVENTIONAL
Ambrocker Weg 60, Germany
Started: Nov 1, 2009
Prevalence of Obstructive Sleep Apnea Syndrome in Sarcoidosis and Impact of CPAP Treatment on Associated Fatigue Status
NCT03926832COMPLETEDNA
68 participants
INTERVENTIONAL
Rome, Italy
Started: Apr 27, 2019
Effects of Treating Obstructive Sleep Apnea in Epilepsy
NCT00047463COMPLETEDPHASE2
68 participants
INTERVENTIONAL
Ann Arbor, United States +3 more
Started: Sep 1, 2002
Anxiety and Depression In Patients With Obstructive Sleep Apnoea Before and After Continuous Positive Airway Pressure
NCT04104880COMPLETEDNA
50 participants
INTERVENTIONAL
Granada, Spain
Started: Apr 1, 2019
CPAP Treatment and Postoperative Outcomes in Patients With Rheumatic Valvular Heart Disease
NCT03398733COMPLETEDNA
32 participants
INTERVENTIONAL
Nanjing, China
Started: Dec 1, 2017
Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome
NCT01808508COMPLETEDNA
27 participants
INTERVENTIONAL
Philadelphia, United States
Started: Sep 1, 2010
CPAP Efficacy in Post-COVID-19 Patients With Sleep Apnea
NCT06052514COMPLETED
22 participants
OBSERVATIONAL
Pittsburgh, United States
Started: Jan 4, 2024
Showing 20 of 650 total trials